BIOMAT Database Logo BIOMAT Database Logo

Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies. 2016

Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S. A. S. Nagar, 160 062, Punjab, India.

The benzo[d]thiazol-2-yl(piperazin-1-yl)methanones scaffold has been identified as new anti-mycobacterial chemotypes. Thirty-six structurally diverse benzo[d]thiazole-2-carboxamides have been prepared and subjected to assessment of their potential anti-tubercular activity through in vitro testing against Mycobacterium tuberculosis H37Rv strain and evaluation of cytotoxicity against RAW 264.7 cell lines. Seventeen compounds showed anti-mycobacterial potential having MICs in the low (1-10) μM range. The 5-trifluoromethyl benzo[d]thiazol-2-yl(piperazin-1-yl)methanones emerged to be the most promising resulting in six positive hits (2.35-7.94 μM) and showed low-cytotoxicity (<50% inhibition at 50 μg/mL). The therapeutic index of these hits is 8-64. The quantitative structure activity relationship has been established adopting a statistically reliable CoMFA model showing high prediction (rpred(2)=0.718,rncv(2)=0.995).

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000077489 Piperazine An anti-nematodal agent effective against the intestinal nematodes ASCARIS LUMBRICOIDES (roundworm) and ENTEROBIUS VERMICULARIS (pinworm, threadworm). It produces a neuromuscular block leading to flaccid muscle paralysis in susceptible worms, which are then dislodged from the gut and expelled in feces. 1,4-Diazacyclohexane,1,4-Piperazine,Piperazine Diacetate,Piperazine Dihydrochloride,Piperazine Hexahydrate,Piperazine Hydrate,Piperazine Hydrobromide,Piperazine Hydrochloride,Piperazine Monohydrochloride,Piperazine Phosphate,Piperazine Phosphate (1:1),Piperazine Phosphate Anhydrous,Piperazine Salt,Piperazine Sulfate,Piperazine Tartrate,Piperazine Tartrate (1:1), (R-(R*,R*))-isomer,Piperazine Tartrate, (R-(R*,R*))-isomer,Piperazinium Oleate,Pripsen,1,4 Diazacyclohexane,1,4 Piperazine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
Synthesis, pharmacological evaluation and docking studies of N-(benzo[d]thiazol-2-yl)-2-(piperazin-1-yl)acetamide analogs as COX-2 inhibitors.
January 2012, Bioorganic & medicinal chemistry letters,
Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
Synthesis and Biological Evaluation of A Series of (Benzo[d]thiazol-2-yl)cyclohexanecarboxamides and (Benzo[d]thiazol-2-yl)cyclohexanecarbothioamides.
May 2010, Medicinal chemistry (Shariqah (United Arab Emirates)),
Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1.
January 2022, Bioorganic chemistry,
Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
February 2021, Bioorganic chemistry,
Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation.
June 2020, Bioorganic chemistry,
Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
α-Sulfonamidophosphonates as new anti-mycobacterial chemotypes: Design, development of synthetic methodology, and biological evaluation.
February 2019, Bioorganic chemistry,
Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.
September 2020, Bioorganic & medicinal chemistry,
Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators.
April 2018, Computational biology and chemistry,
Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents.
October 2021, Bioorganic chemistry,
Sahaj Pancholia, and Tejas M Dhameliya, and Parth Shah, and Pradeep S Jadhavar, and Jonnalagadda Padma Sridevi, and Perumal Yogeshwari, and Dharmarajan Sriram, and Asit K Chakraborti
New benzo[d]thiazol-2-yl-aminoacetamides as potential anticonvulsants: synthesis, activity and prediction of molecular properties.
April 2015, Archiv der Pharmazie,
Copied contents to your clipboard!